| Bioactivity | (E)-8-(3-Chlorostyryl)caffeine is a selective adenosine A2A receptor antagonist. (E)-8-(3-Chlorostyryl)caffeine inhibits monoamine oxidase B (MAO-B) with a Ki value of 70 nM by a pathway that is independent of its actions on the A2A receptor. (E)-8-(3-Chlorostyryl)caffeine has the potential for Parkinson's disease research[1]. |
| Name | (E)-8-(3-Chlorostyryl)caffeine |
| CAS | 147700-11-6 |
| Formula | C16H15ClN4O2 |
| Molar Mass | 330.77 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Nevil Vlok, et al. Inhibition of monoamine oxidase B by analogues of the adenosine A2A receptor antagonist (E)-8-(3-chlorostyryl)caffeine (CSC). Bioorg Med Chem. 2006 May 15;14(10):3512-21. |
(E)-8-(3-Chlorostyryl)caffeine
CAS: 147700-11-6 F: C16H15ClN4O2 W: 330.77
(E)-8-(3-Chlorostyryl)caffeine is a selective adenosine A2A receptor antagonist. (E)-8-(3-Chlorostyryl)caffeine inhibits
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.